In Vivo Imaging of Lymph Node Migration of MNP- and 111In-Labeled Dendritic Cells in a Transgenic Mouse Model of Breast Cancer (MMTV-Ras)
暂无分享,去创建一个
Carlo Fiorini | Cristina Martelli | Giovanni Lucignani | Mario Clerici | G. Lucignani | M. Clerici | S. Bosari | C. Fiorini | U. Gianelli | D. Trabattoni | L. Ottobrini | Anna Degrassi | Luisa Ottobrini | Daria Trabattoni | Silvano Bosari | C. Martelli | M. Borelli | V. Rainone | A. Degrassi | M. Russo | Veronica Rainone | Manuela Borelli | Micaela Russo | Umberto Gianelli
[1] E T Ahrens,et al. Receptor‐mediated endocytosis of iron‐oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging , 2003, Magnetic resonance in medicine.
[2] T. Scheenen,et al. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines , 2006, International journal of cancer.
[3] A. Devillers,et al. Biodistribution of radiolabelled human dendritic cells injected by various routes , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[4] G. Lucignani,et al. Molecular imaging of cell-mediated cancer immunotherapy. , 2006, Trends in biotechnology.
[5] Hisataka Kobayashi,et al. In vivo real-time, multicolor, quantum dot lymphatic imaging. , 2009, The Journal of investigative dermatology.
[6] H. Soltau,et al. The DRAGO gamma camera. , 2010, The Review of scientific instruments.
[7] G. Schuler,et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. , 1999, Journal of immunological methods.
[8] P. Foster,et al. In Vivo Cellular MRI of Dendritic Cell Migration Using Micrometer-Sized Iron Oxide (MPIO) Particles , 2011, Molecular Imaging and Biology.
[9] F. Sallusto,et al. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. , 2001, Current opinion in immunology.
[10] A. Moretti,et al. Evaluation of in vivo labelled dendritic cell migration in cancer patients , 2004, Journal of Translational Medicine.
[11] Masafumi Nakamura,et al. Combination therapy with tumor cell-pulsed dendritic cells and activated lymphocytes for patients with disseminated carcinomas. , 2005, Anticancer research.
[12] S. Aamdal,et al. Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA , 2006, Cancer Gene Therapy.
[13] Yi Lu,et al. Smart “Turn‐on” Magnetic Resonance Contrast Agents Based on Aptamer‐Functionalized Superparamagnetic Iron Oxide Nanoparticles , 2007, Chembiochem : a European journal of chemical biology.
[14] P. Leder,et al. Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. , 1989, The American journal of pathology.
[15] E. Ahrens,et al. Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. , 2010, Cytotherapy.
[16] J. Timmerman,et al. Dendritic cell vaccines for cancer immunotherapy. , 1999, Annual review of medicine.
[17] Ralph Weissleder,et al. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. , 2002, Bioconjugate chemistry.
[18] H. Johnsen,et al. Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers , 2007, Cancer Immunology, Immunotherapy.
[19] R. Levy,et al. Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma. , 2006, Cytotherapy.
[20] Xiaoyuan Chen,et al. Nanoparticles for cell labeling. , 2011, Nanoscale.
[21] Kazushi Inoue,et al. MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer , 2009, Expert review of molecular diagnostics.
[22] Keith L. Black,et al. Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma , 2004, Cancer Research.
[23] J. Banchereau,et al. Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging , 2010, Magnetic resonance in medicine.
[24] S. Laurent,et al. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study. , 2008, Contrast media & molecular imaging.
[25] H. Lyerly,et al. Dendritic cell vaccines. , 2007, Frontiers in bioscience : a journal and virtual library.
[26] R. Weissleder,et al. Cell Internalization of Magnetic Nanoparticles Using Transfection Agents , 2007, Molecular imaging.
[27] M. Erturk,et al. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study. , 2007, Journal of experimental & clinical cancer research : CR.
[28] H. Ueno,et al. Dendritic Cells Loaded With Killed Allogeneic Melanoma Cells can Induce Objective Clinical Responses and MART-1 Specific CD8+ T-cell Immunity , 2006, Journal of immunotherapy.
[29] W. Van den Broeck,et al. Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. , 2006, Journal of immunological methods.
[30] Ralph Weissleder,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.
[31] Z. Gu,et al. Self-assembly of magnetite nanocrystals with amphiphilic polyethylenimine: structures and applications in magnetic resonance imaging. , 2009, Journal of nanoscience and nanotechnology.
[32] Antonio Lanzavecchia,et al. Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.
[33] J. Gore,et al. Magnetic nanoparticles for imaging dendritic cells , 2010, Magnetic resonance in medicine.
[34] C. Corot,et al. Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation. , 1996, Academic radiology.
[35] Jinming Gao,et al. Nonclustered magnetite nanoparticle encapsulated biodegradable polymeric micelles with enhanced properties for in vivo tumor imaging , 2011 .
[36] E. Mittendorf,et al. Evaluation of the HER2/neu‐derived peptide GP2 for use in a peptide‐based breast cancer vaccine trial , 2006, Cancer.
[37] B. Neyns,et al. Current approaches in dendritic cell generation and future implications for cancer immunotherapy , 2007, Cancer Immunology, Immunotherapy.
[38] Andreas Hess,et al. In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice , 2006, European journal of immunology.
[39] Parag Aggarwal,et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.
[40] M. Lutz,et al. Non-invasive imaging of dendritic cell migration in vivo. , 2006, Immunobiology.
[41] J. Fay,et al. Dendritic cell based tumor vaccines. , 2000, Immunology letters.
[42] R. Maldonado-López,et al. Dendritic cell subsets and the regulation of Th1/Th2 responses. , 2001, Seminars in immunology.
[43] Arend Heerschap,et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.
[44] W. Ge,et al. Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo. , 2006, World journal of gastroenterology.
[45] E. Zappi,et al. Combined Fontana-Masson/Perls' staining. , 1984, The American Journal of dermatopathology.
[46] G. Hager,et al. Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus , 1981, Cell.
[47] Donald S. Williams,et al. Detection of single mammalian cells by high-resolution magnetic resonance imaging. , 1999, Biophysical journal.
[48] J. Gore,et al. Dendritic cells: therapy and imaging , 2009, Expert opinion on biological therapy.
[49] E. Gilboa. DC-based cancer vaccines. , 2007, The Journal of clinical investigation.
[50] V. Cerundolo,et al. Dendritic cells: a journey from laboratory to clinic , 2004, Nature Immunology.
[51] J. Hay,et al. Measurement of lymphocyte traffic with indium-111. , 1980, Clinical and experimental immunology.
[52] Stephanie E. A. Gratton,et al. The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.
[53] T. C. Jones,et al. ANIMAL MODELS OF HUMAN DISEASE , 2009 .
[54] S. Hudak,et al. The CC Chemokine Receptor-7 Ligands 6Ckine and Macrophage Inflammatory Protein-3β Are Potent Chemoattractants for In Vitro- and In Vivo-Derived Dendritic Cells , 1999, The Journal of Immunology.
[55] J. Villadangos,et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. , 2006, Immunity.